Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 11 04:00PM ET
17.55
Dollar change
-0.03
Percentage change
-0.17
%
Index- P/E- EPS (ttm)-16.85 Insider Own77.36% Shs Outstand3.34M Perf Week7.54%
Market Cap227.10M Forward P/E- EPS next Y-3.10 Insider Trans13.61% Shs Float0.76M Perf Month-4.72%
Income-56.54M PEG- EPS next Q-1.10 Inst Own98.05% Short Float91.29% Perf Quarter27.17%
Sales0.00M P/S- EPS this Y89.50% Inst Trans- Short Ratio16.59 Perf Half Y10.38%
Book/sh23.00 P/B0.76 EPS next Y-17.20% ROA-49.87% Short Interest0.69M Perf Year-72.81%
Cash/sh5.93 P/C2.96 EPS next 5Y- ROE-54.00% 52W Range9.80 - 77.60 Perf YTD9.69%
Dividend Est.- P/FCF- EPS past 5Y-50.29% ROI-73.08% 52W High-77.38% Beta0.21
Dividend TTM- Quick Ratio57.86 Sales past 5Y0.00% Gross Margin- 52W Low79.06% ATR (14)1.25
Dividend Ex-Date- Current Ratio57.86 EPS Y/Y TTM27.87% Oper. Margin0.00% RSI (14)52.02 Volatility8.13% 7.20%
Employees8 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price35.33
Option/ShortNo / Yes LT Debt/Eq0.01 EPS Q/Q75.18% Payout- Rel Volume1.13 Prev Close17.58
Sales Surprise- EPS Surprise-60.00% Sales Q/Q- EarningsAug 13 BMO Avg Volume41.83K Price17.55
SMA20-0.72% SMA506.00% SMA2007.75% Trades Volume47,358 Change-0.17%
Date Action Analyst Rating Change Price Target Change
Oct-10-24Initiated Oppenheimer Outperform $35
Dec-15-23Downgrade Leerink Partners Outperform → Market Perform
Dec-15-23Downgrade Jefferies Buy → Hold
Dec-15-23Downgrade H.C. Wainwright Buy → Neutral $30 → $1.50
Dec-14-23Downgrade William Blair Outperform → Mkt Perform
Dec-14-23Downgrade Robert W. Baird Outperform → Neutral $28 → $3
Dec-14-23Downgrade Piper Sandler Overweight → Neutral $25 → $4
Dec-14-23Downgrade Ladenburg Thalmann Buy → Neutral
Dec-14-23Downgrade BofA Securities Buy → Underperform $23 → $1.45
Nov-15-23Initiated William Blair Outperform $35.55
Nov-05-24 04:05PM
Nov-01-24 05:30PM
Oct-07-24 04:32AM
Oct-04-24 04:57PM
Oct-02-24 08:20PM
07:35AM Loading…
Aug-13-24 07:35AM
May-16-24 10:01AM
May-13-24 08:25AM
07:35AM
May-07-24 01:53PM
07:35AM
Mar-28-24 12:53PM
07:35AM
Mar-25-24 07:00AM
Dec-21-23 04:13PM
10:19AM Loading…
Dec-15-23 10:19AM
Dec-14-23 12:35PM
09:05AM
Nov-13-23 05:04PM
07:35AM
Nov-02-23 07:50AM
Oct-25-23 07:50AM
Oct-20-23 01:22PM
Oct-09-23 07:50AM
Oct-06-23 08:30AM
Aug-29-23 07:35AM
Aug-10-23 07:35AM
07:31AM
Jul-27-23 11:19AM
Jun-30-23 08:25AM
08:25AM Loading…
Jun-26-23 08:25AM
Jun-15-23 12:44PM
May-31-23 10:38AM
08:00AM
May-21-23 07:42PM
May-12-23 06:00PM
May-11-23 07:45AM
May-03-23 11:36PM
04:01PM
Mar-27-23 07:30AM
Mar-14-23 07:30AM
Mar-09-23 08:00AM
Mar-03-23 06:07AM
Feb-02-23 07:35AM
Jan-31-23 07:35AM
Dec-04-22 07:12AM
Nov-08-22 07:35AM
Nov-03-22 08:00AM
Sep-14-22 06:02AM
Sep-06-22 08:35AM
Aug-29-22 07:35AM
Aug-09-22 08:00AM
Aug-04-22 09:10AM
Aug-02-22 07:30AM
Jul-26-22 09:52AM
07:30AM
Jul-11-22 08:00AM
Jun-30-22 08:00AM
Jun-20-22 08:33AM
May-10-22 04:05PM
Mar-23-22 04:05PM
Mar-07-22 08:30AM
Feb-02-22 08:00AM
Jan-24-22 08:00AM
Jan-10-22 11:55AM
Dec-22-21 11:04AM
Nov-11-21 04:05PM
Nov-01-21 04:05PM
Oct-14-21 08:00AM
Oct-11-21 02:35PM
08:00AM
Sep-28-21 08:26AM
Sep-09-21 09:12AM
Aug-11-21 05:55AM
Jul-28-21 08:00AM
Jul-12-21 09:30AM
Jul-09-21 08:00AM
Jul-07-21 08:00AM
Jun-29-21 08:00AM
May-20-21 06:00AM
May-19-21 06:00AM
Apr-13-21 08:14AM
Apr-09-21 12:32PM
Apr-08-21 09:42PM
OnKure Therapeutics, Inc. engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure and computational chemistry driven drug design platform, committed to improving clinical outcomes for patients by building a robust pipeline of small molecule drugs designed to selectively target specific mutations thought to be key drivers of cancer. It is headquartered in Boulder, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Leonard Braden Michael10% OwnerSep 25 '24Buy1.5068,746102,8723,457,395Sep 26 09:33 AM
Leonard Braden Michael10% OwnerSep 24 '24Buy1.4129,60041,8663,388,649Sep 26 09:33 AM
Leonard Braden Michael10% OwnerSep 17 '24Buy1.3655,30075,1083,358,243Sep 19 11:02 AM
Leonard Braden Michael10% OwnerSep 18 '24Buy1.408061,1283,359,049Sep 19 11:02 AM
Leonard Braden Michael10% OwnerSep 16 '24Buy1.37172,747236,8713,302,943Sep 16 04:15 PM
Leonard Braden Michael10% OwnerSep 13 '24Buy1.31150,000196,9503,130,196Sep 16 04:15 PM
Leonard Braden Michael10% OwnerSep 12 '24Buy1.4036,17650,5232,980,196Sep 16 04:15 PM
Leonard Braden Michael10% OwnerAug 13 '24Buy1.39171,339238,5902,843,533Aug 14 08:48 PM
Leonard Braden Michael10% OwnerAug 14 '24Buy1.41100,487142,0082,944,020Aug 14 08:48 PM
Leonard Braden Michael10% OwnerMay 14 '24Buy1.54414,281639,5782,672,194May 16 08:58 AM